Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination

Photochemistry and Photobiology

Volumn 70, Issue 6, 1999, Pages 921-929

  Van Der Veen, Nynke ^a   Hebeda, Konnie M ^b   De Bruijn, Henriëtte S ^a   Star, Willem M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; ENTEROBACTERIA PHAGE T4;

AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT;

ANIMAL; ARTICLE; DISEASE MODEL; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; HAIRLESS MOUSE; HISTOLOGY; METHODOLOGY; MOUSE; PHOTOCHEMOTHERAPY; SKIN; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET RADIATION; VASCULARIZATION; VASOCONSTRICTION;

ADMINISTRATION, TOPICAL; AMINOLEVULINIC ACID; ANIMALS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; MICE; MICE, INBRED HRS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN; ULTRAVIOLET RAYS; VASOCONSTRICTION;

EID: 0033253783     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.1999.tb08303.x     Document Type: Article

References (37)

1. Divaris, D. X. G., J. C. Kennedy and R. H. Pottier ( 1990) Photodynamic damage of sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with protoporphyrin IX fluorescence. Am. J. Pathol. 136, 891-897.
2. Loh, C. S., D. Vernon, A. J. MacRobert, J. Bedwell, S. G. Bown and S. B. Brown (1993) Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in tissue layers of the gastrointestinal tract. J. Photochem. Photobiol B Biol. 20, 47-54.
3. Kennedy, J. C., R. H. Pottier and D. C. Pross (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B Biol. 6, 143-148.
4. Kennedy, J. C. and R. H. Pottier (1992) Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol. B Biol. 14, 275-292.
5. Cairnduff, F., M. R. Stringer, E. J. Hudson, D. V. Ash and S. B. Brown (1994) Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer. Br. J. Cancer 69, 605-608.
6. Lui, H., S. Salasche, N. Kollias, J. Wimberly, T. Flotte, D. McLean D and R. R. Anderson (1995) Photodynamic therapy of nonmelanoma skin cancer with topical aminolevulinic acid: a clinical and histologic study. Arch. Dermatol. 131, 737-738.
7. Meijnders, P. J. N., W. M. Star, R. S. de Bruijn, A. D. Treurniet-Donker, M. J. M. van Mierlo, S. J. M. Wijthoff, B. Naafs, H. Beerman and P. C. Levendag (1996) Clinical results of photodynamic therapy for superficial skin malignancies or actinic keratosis using topical 5-aminolaevulinic acid, Lasers Med. Sci. 11, 123-131.
8. Stables, G. I., M. R. Stringer, D. J. Robinson and D. V. Ash (1997) Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy. Br. J. Dermatol. 136, 957-960.
9. Svanberg, K., T. Andersson, D. Killander, I. Wang, U. Stenram, S. Andersson-Engels, R. Berg, J. Johansson and S. Svanberg (1994) Photodynamic therapy of non-melanoma malignant tumours of the skin using topical 5-aminolevulinic acid sensitisation and laser irradiation. Br. J. Dermatol. 130, 743-751.
10. Wolf, P., E. Rieger and H. Kerl (1993) Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J. Am. Acad. Dermatol. 28, 17-21.
11. Fink-Puches, R., H. P. Soyer, A. Hofer, H. Kerl and P. Wolf (1998) Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical 8-aminolevulinic acid photodynamic therapy. Arch. Dermatol 134, 821-826.
12. Szeimies, R. M., T. Sassy and M. Landthaler (1994) Penetration potency of topical applied aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Photochem. Photobiol. 59, 73-76.
13. Calzavara-Pinton, P. G. (1995) Repetitive photodynamic therapy with topical 5-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J. Photochem. Photobiol. B Biol. 29, 53-57.
14. Warloe, T., Q. Peng, H. Heyerdahl, J. Moan, H. B. Steen and K. E. Giercksky (1995) Photodynamic therapy with 5-aminolevulinic acid induced porphyrins and DMSO/EDTA for basal cell carcinoma. Proc. SPIE 2371, 226-235.
15. Fijan, S., H. Hönigsmann and B. Ortel (1995) Photodynamic therapy of epithelial skin tumours using delta-aminolevulinic acid and desferrioxamine. Br J. Dermatol. 133, 282-288.
16. Morton, C. A., C. Whitehurst, H. Moseley, J. V. Moore and R. M. Mackie (1995) Development of an alternative light source to lasers for photodynamic therapy. 3. Clinical evaluation in the treatment of pre-malignant non-melanoma skin cancer. Lasers Med. Sci. 10, 165-171.
17. Orenstein, A., G. Kostenich, H. Tsur, L. Roitman, B. Ehrenberg and Z. Malik (1994) Photodynamic therapy of human skin tumors using topical application of 5-aminolevulinic acid, DMSO and EDTA. Proc. SPIE 2325, 100-105.
18. Berg, K., H. Anholt, O. Bech and J. Moan (1996) The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolevulinic acid-treated cells. Br. J. Cancer 74, 688-697.
19. De Gruijl, F. R., J. B. van der Meer and J. C. van der Leun (1983) Dose-time dependency of tumor formation by chronic UV exposure. Photochem. Photobiol. 37, 53-62.
20. Fears, T. R., J. Scotto and M. Schneiderman (1976) Skin cancer, melanoma and sunlight. Am. J. Public Health 66, 461-464.
21. Sterenborg, H. J. C. M., F. R. de Gruijl and J. C. van der Leun (1986) UV-induced epidermal hyperplasia in hairless mice. Photodermatology 3, 206-214.
22. Robinson, D. J., R. S. de Bruijn, N. van der Veen, M. R. Stringer, S. B. Brown and W. M. Star (1998) Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and fluence rate and the resulting biological effect. Photochem. Photobiol. 67, 140-149
23. Robinson, D. J., H. S. de Bruijn, N. van der Veen, M. R. Stringer, S. B. Brown and W. M. Star (1999) Protoporphyrin IX fluorescence photobleaching during ALA-mediated photodynamic therapy of UVB-induced tumors in hairless mouse skin. Photochem. Photobiol. 69: 61-70.
24. Van der Veen, N., H. S. de Bruijn, R. J. W. Berg and W. M. Star (1996) Kinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumours of UVB-treated mice. Br. J. Cancer 73, 925-930.
25. Van Staveren, H. J., J. P. A. Marijnissen, M. C. G. Aalders and W. M. Star (1995) Construction, quality control and calibration of spherical isotropic fibre-optic light diffusers. Lasers Med. Sci. 10, 137-147.
26. Bellnier, D. A., W. R. Potter, L. A. Vaughan, T. M. Sitnik, J. C. Parson, W. R. Greco, J. Whitaker, P. Johnson and B. W. Henderson (1995) The validation of a new vascular damage assay for photodynamic therapy agents. Photochem. Photobiol. 62, 896-905.
27. Fingar, V. H. and B. W. Henderson (1987) Drug and light dose dependence of photodynamic therapy: a study of tumour and normal tissue response. Photochem. Photobiol. 46, 837-841.
28. Cheong, W. F., S. A. Prahl and A. J. Welch (1990) A review of the optical properties of biological tissues. IEEE J. Quantum Electron. 26, 2166-2185.
29. Van der Veen, N., H. S. de Bruijn and W. M. Star (1997) Photobleaching during and re-appearance after photodynamic therapy of topical ALA-induced fluorescence in UVB-treated mouse skin. Int. J. Cancer 72, 110-118.
30. Hua, Z., S. L. Gibson, T. H. Foster and R. Hilf (1995) Effectiveness of 5-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. Cancer Res. 55, 1723-1731.
31. De Bruijn, H. S., N. Van der Veen, D. J. Robinson and W. M. Star (1999) Improvement of systemic 5-aminolevulinic acid-based photodynamic therapy in vivo using light fractionation with a 75-minute interval. Cancer Res. 59: 901-904.
32. Van der Veen, N., H. L. L. M. van Leengoed and W. M. Star (1994) In vivo fluorescence and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations. Br. J. Cancer 70, 867-872.
33. Wang, I., S. Andersson-Engels, G. E. Nilsson, K. Wardell and K. Svanberg (1997) Superficial blood flow following photodynamic therapy of malignant non-melanoma skin tumours measured by laser Doppler perfusion imaging. Br. J. Dermatol. 136, 184-189.
34. He, D., S. Sassa and H. W. Lim (1993) Effect of UVA and blue light on porphyrin biosynthesis in epidermal cells. Photochem. Photobiol. 57: 825-829.
35. Orenstein, A., G. Kostenich and Z. Malik (1997) The kinetics of protoporphyrin fluorescence during ALA-PDT in human malignant skin tumors. Cancer Lett. 120: 229-234.
36. Af Klinteberg, C., A. M. K. Enejder, I. Wang, S. Andersson-Engels, S. Svanberg and K. Svanberg (1999) Kinetic fluorescence studies of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation in basal cell carcinomas. J. Photochem. Photobiol. B Biol. 49: 120-128.
37. Curnow, A., B. W. McIlroy, M. J. Postle-Hacon, A. J. MacRobert and S. G. Bown (1999) Light dose fractionation to enhance photodynamic therapy using 5-aminolaevulinic acid in the normal rat colon. Photochem. Photobiol. 69, 71-76.